Hari Gnanasekeram
Cardiovascular Disease · Chambersburg, PANPI 1881867018
Payments from drug & device makers
Across 971 payments — averaging $285.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$114K
- Lantheus Medical Imaging, Inc.$49K
- AstraZeneca$48K
- Lilly USA, LLC$17K
- Novo Nordisk$17K
- Esperion Therapeutics, Inc.$9K
- plus $24K from 29 others
What the payments were for
- Consulting fees$19,6007%
- Speaking & faculty fees$213,73377%
- Travel & lodging$19,3667%
- Food & beverage$24,5359%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 192 | $113,990 |
| Lantheus Medical Imaging, Inc. | 59 | $48,728 |
| AstraZeneca | 74 | $47,580 |
| Lilly USA, LLC | 21 | $17,153 |
| Novo Nordisk | 18 | $16,514 |
| Esperion Therapeutics, Inc. | 23 | $9,363 |
| Biotronik Inc. | 58 | $7,339 |
| Johnson & Johnson | 135 | $3,273 |
| Boston Scientific | 12 | $3,100 |
| E.r. Squibb & Sons, L.L.C. | 95 | $2,282 |
| Medtronic(2 entities) | 25 | $1,750 |
| Amgen | 46 | $1,599 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 37 | $933 |
| Novartis | 49 | $778 |
| Bayer | 30 | $637 |
| Pfizer | 43 | $560 |
| Impulse Dynamics (USA) Inc. | 6 | $323 |
| Abiomed | 7 | $301 |
| Sanofi-aventis U.S. LLC | 8 | $248 |
| Philips North America LLC | 6 | $123 |
| Corcept Therapeutics | 1 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| Biosense Webster, Inc. | 3 | $80 |
| Merck | 5 | $72 |
| Actelion Pharmaceuticals US, Inc. | 1 | $64 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Altathera Pharmaceuticals LLC | 2 | $49 |
| Amarin Pharma, Inc. | 3 | $41 |
| Convatec Inc. | 1 | $38 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $21 |
| Akcea Therapeutics, Inc. | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Abbott | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$277,257 in reported general payments places this provider in the 95th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 47 | $41,743 |
| JardianceEmpagliflozin | 25 | $39,508 |
| XareltoRivaroxaban | 18 | $14,857 |
| FarxigaDapagliflozin Propanediol | 14 | $14,716 |
| Metoprolol Succinate | 18 | $339 |
| Atorvastatin Calcium | 18 | $268 |
| Losartan Potassium | 12 | $201 |
| ClopidogrelClopidogrel Bisulfate | 13 | $175 |
| Metoprolol Tartrate | 27 | $122 |
| Furosemide | 21 | $87 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $560 | $41,74347 claims |
| Boehringer IngelheimJardiance | $113,990 | $39,50825 claims |
| Johnson & JohnsonXarelto | $3,273 | $14,85718 claims |
| AstraZenecaFarxiga | $47,580 | $14,71614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Other cardiovascular disease in Chambersburg
- Danielle DuffyPhiladelphia$29.5M
- Venkatesh NadarCamp Hill$18.3M
- Hemal GadaWormleysburg$6.7M
- Brian DrachmanPhiladelphia$3.8M
- William BachinskyMechanicsburg$2.3M
- Bonnie KyPhiladelphia$1.9M
- Benjamin KalsmithPgh$1.7M
- Marielle Scherrer CrosbiePhiladelphia$1.6M
- Paul GrenaYardley$1.6M
- Peter KoweyWynnewood$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.